FIELD: biotechnologies.
SUBSTANCE: method is proposed to develop the specified structure, which includes: a) development of at least two modules, where each module is independently made in the form of a nucleus that carries molecules of the first protein and the second protein on the surface, where the first protein is barnase, and the second protein is barstar, besides, the first or second protein for binding with each module is selected in the following manner: the first module is made as carrying protein molecules on its surface selected from the first protein or the second protein; the second module is performed as carrying protein molecules on the surface selected from the first protein or the second protein and different from the protein contained in the first module; the third and each subsequent module carries molecules of either the first or the second protein on the surface; b) combination of the first, second and subsequent modules, in which modules are self-assembled in the structure due to interaction of the molecules of barnase and barstart, besides, nuclei of at least two of the specified modules are made with particles of supermolecular nature. The structure is described for diagnostics and therapy produced by the specified method.
EFFECT: invention makes it possible to produce structures including nuclei of different nature and size connected to each other by means of a functional pair barnase-barstar, providing for tight connection of the specified nuclei.
20 cl, 5 dwg, 8 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING COMPLEX FOR TUMOR THERAPEUTICS BASED ON ANTI-STOKES NANOPHOSPHORS AND PROTEIN MOLECULES | 2020 |
|
RU2745187C1 |
METHOD OF IMMUNOFLUORESCENT DETERMINATION OF ANTIGENS LOCALISATION | 2006 |
|
RU2350959C2 |
RECOMBINANT SARS-CoV-2 S PROTEIN RBD-BINDING PROTEIN | 2022 |
|
RU2778942C1 |
RECOMBINANT PLASMID PROVIDING SYNTHESIS OF BARNASE IN CELLS OF ESCHERICHIA COLI, ESCHERICHIA COLI STRAIN - PRODUCER OF BARNASE AND METHOD FOR PRODUCING BARNASE | 2017 |
|
RU2650871C1 |
METHOD OF PRODUCING RECOMBINANT ANTI-TUMOR TOXIN BASED ON PROTEIN BARNASE-BARSTAR AND TARGETED POLYPEPTIDE DARPIN WITH EFFECT OF INSTANT CANCELLATION OF CYTOTOXIC ACTION | 2015 |
|
RU2610179C1 |
CARRIER FOR DIAGNOSING, DIRECTED DELIVERY AND CONTROLLED RELEASE OF MEDICINAL AGENTS | 2018 |
|
RU2693485C1 |
FLUORESCENT MULTI-PURPOSE NANOSCALE LABEL AND CONJUGATES BASED THEREON | 2021 |
|
RU2777648C1 |
POLYPEPTIDE WITH ANTI-SARS-COV-2 ACTIVITY AND PROLONGED CIRCULATION TIME IN BLOOD FLOW | 2023 |
|
RU2822355C1 |
CONJUGATE OF LUMINESCENT SILICON DIOXIDE NANOPARTICLES WITH RECOMBINANT SINGLE-DOMAIN C7B LAMA NANO-MONOANTIBODIES, CAPABLE OF SPECIFICALLY INTERACTING WITH RECOMBINANT HER2/NEU PROTEIN - ANALOGUE OF EPIDERMAL GROWTH FACTOR NATURAL RECEPTOR EGFR/ERBB OF HUMAN CELLS | 2017 |
|
RU2679075C1 |
MAGNETIC AFFINITY SORBENT FOR ISOLATION OF RECOMBINANT PROTEINS | 2022 |
|
RU2794889C1 |
Authors
Dates
2013-04-27—Published
2010-09-13—Filed